Author

Alan Xu

Institution: The University of Texas MD Anderson Cancer Center

Observed institution: The University of Texas MD Anderson Cancer Center

OpenAlex ID: A5004643221

Discovery of IPN60090, a Clinical Stage Selective Glutaminase‑1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties

2020 · Michael J. Soth, Kang Le, et al. · Journal of Medicinal Chemistry · 106

Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme

2021 · Matthew M. Hamilton, Faika Mseeh, et al. · Journal of Medicinal Chemistry · 28

Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy

2023 · Kang Le, Michael J. Soth, et al. · Journal of Medicinal Chemistry · 23

Works count: 3

Citation count: 157

H-index: 3

I10-index: 3